Medicines 
Dealstreet

Samisti Legal, Trilegal act on Piramal Pharma acquiring minority stake in Yapan Bio for ₹101.77 crore

The acquisition took place through primary and secondary purchase of shares.

Bar & Bench

Piramal Pharma acquires minority stake in Yapan Bio for ₹101.77 crore.

Samisti Legal acted as the legal counsel to Yapan Bio. The team was led by Prashant Jain (Partner) and assisted by Anita Dugar (Principal Associate).

Trilegal acted for Piramal Pharma.

The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its Contract Development and Manufacturing Organization (CDMO) business, by broadening its service offerings.

The acquisition took place through primary and secondary purchase of shares.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

JSA advises YES Bank on ₹519 crore financing provided to First Energy group

Sonam Wangchuk in sound health, was allowed to draft representation: Leh administration to Supreme Court

SNG & Partners acts on Lodha Developers ₹500 crore NCD Issuance

SAM, Khaitan act on WeWork India ~₹300 crore IPO

Three judges transferred to Andhra Pradesh High Court

SCROLL FOR NEXT